Pacira Biosciences (PCRX) Stock: Gaining Big On HRTX Failure

Pacira Biosciences PCRX Stock News

Pacira Biosciences Inc (NASDAQ: PCRX) is having an overwhelmingly strong start to the trading session this morning. However, if you’re digging for press releases or SEC filings, don’t hold your breath. There’s nothing out there. Nonetheless, there is a very good reason for the gains. Ultimately, the comapny is seeing gains as the result of … Read more

Heron Therapeutics (HRTX) Stock: Tumbling On FDA Rejection

Heron Therapeutics HRTX Stock News

Heron Therapeutics Inc (NASDAQ: HRTX) is having an overwhelmingly rough day in the market today, and for good reason. The company announced that the FDA has rejected a New Drug Application (NDA), upsetting investors who are sending the stock tumbling. Today, we’ll talk about: The FDA rejection; what we’re seeing from HRTX stock as a … Read more

Heron Therapeutics (HRTX) Stock: Gaining Big On Clinical Update

Heron Therapeutics Inc (NASDAQ: HRTX) is flying early on in the market this morning, and for good reason. Not only did the company report positive data from multiple clinical studies, it also announced positive feedback from the FDA, leading to Breakthrough Therapy Designation. Of course, the news proved to excite investors, sending HRTX on a … Read more

Heron Therapeutics (HRTX) Stock: Climbing On Strong Clinical Results

Heron Therapeutics Inc (NASDAQ: HRTX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced clinical results that proved to be positive, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about the results, what we’re seeing from the stock, … Read more

Morning Buzz: Prana Biotechnology (PRAN), Heron Therapeutics (HRTX), Vascular Biogenics (VBLT), Clovis Oncology (CLVS)

Prana Biotechnology Limited (PRAN) shares surged 19.26% to $1.61 in early trading following the company’s announcement that the European Commission has approved orphan designation for PBT2 for the treatment of Huntington’s disease, stating that Prana has shown that PBT2 might be of significant benefit for patients with Huntington’s disease. Shares of Heron Therapeutics, Inc. (HRTX) … Read more